The Role of Chemokines and Small Leucine-Rich Proteoglycans in Cardiac Remodeling in Immunosuppressant-Treated Male Rats
Abstract
1. Introduction
2. Results
2.1. The Expression of CXCR5 Protein in Hearts
2.2. The Concentration of CXCL13 in Hearts
2.3. The Concentration of Fibromodulin in Hearts
3. Discussion
4. Materials and Methods
4.1. Tissue Homogenization and Protein Concentration Determination
4.2. The Western Blot Analysis of CXCR5
4.3. The Determination of CXCL13 and Fibromodulin Concentration Using ELISA
4.4. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Newland, D.M.; Nemeth, T.L. Induction and Standard Immunosuppression. In Solid Organ Transplantation in Infants and Children; Dunn, S.P., Horslen, S., Eds.; Organ and Tissue Transplantation; Springer International Publishing: Cham, Switzerland, 2018; pp. 149–182. [Google Scholar] [CrossRef]
- Chang, D.H.; Youn, J.-C.; Dilibero, D.; Patel, J.K.; Kobashigawa, J.A. Heart Transplant Immunosuppression Strategies at Cedars-Sinai Medical Center. Int. J. Heart Fail. 2020, 3, 15–30. [Google Scholar] [CrossRef]
- Arnol, M.; Naumovic, R.; Dimitrov, E.P.; Racki, S.; Bucsa, C.A.; Covic, A.; Mitic, I.; Vavic, N.; Radovanovic, R.M.V.; Zibar, L.; et al. Immunosuppressive regimens following kidney transplantation in five European countries: The observational RECORD study. Transplant. Rep. 2020, 5, 100061. [Google Scholar] [CrossRef]
- Neuwirt, H.; Rudnicki, M.; Schratzberger, P.; Pirklbauer, M.; Kronbichler, A.; Mayer, G. Immunosuppression after renal transplantation. Memo-Mag. Eur. Med. Oncol. 2019, 12, 216–221. [Google Scholar] [CrossRef]
- Surówka, A.; Żołnierczuk, M.; Prowans, P.; Grabowska, M.; Kupnicka, P.; Markowska, M.; Olejnik-Wojciechowska, J.; Szlosser, Z.; Wilk, A.; Szumilas, K.; et al. The Effects of Chronic Immunosuppressive Treatment on Morphological Changes in Cardiac Tissue and the Balance between Matrix Metalloproteinases (MMP-2 and MMP-9) and Their Inhibitors in the Rat Heart. Int. J. Mol. Sci. 2024, 25, 4468. [Google Scholar] [CrossRef] [PubMed]
- Surówka, A.; Szumilas, K.; Wilk, A.; Misiakiewicz-Has, K.; Ciechanowski, K.; Kędzierska-Kapuza, K. The Effect of Chronic Immunosuppressive Regimens Treatment on Aortal Media Morphology and the Balance between Matrix Metalloproteinases (mmp-2 and mmp-9) and Their Inhibitors in the Abdominal Aorta of Rats. Int. J. Environ. Res. Public Health 2022, 19, 6399. [Google Scholar] [CrossRef]
- Hussain, Y.; Khan, H. Immunosuppressive Drugs. Encycl. Infect. Immun. 2022, 4, 726–740. [Google Scholar] [CrossRef]
- Fishman, J.A. Opportunistic Infections—Coming to the Limits of Immunosuppression? Cold Spring Harb. Perspect. Med. 2013, 3, a015669. [Google Scholar] [CrossRef]
- Parlakpinar, H.; Gunata, M. Transplantation and immunosuppression: A review of novel transplant-related immunosuppressant drugs. Immunopharmacol. Immunotoxicol. 2021, 43, 651–665. [Google Scholar] [CrossRef]
- Elezaby, A.; Dexheimer, R.; Sallam, K. Cardiovascular effects of immunosuppression agents. Front. Cardiovasc. Med. 2022, 9, 981838. [Google Scholar] [CrossRef]
- Surówka, A.; Prowans, P.; Żołnierczuk, M.; Miśkiewicz, M.; Wawrowski, T.; Skodda, M.; Markowska, M.; Kędzierska-Kapuza, K. The Effect of Calcineurin Inhibitors on MMPs Activity in Heart and Their Side Effects—A Review of Literature. Int. J. Mol. Sci. 2023, 24, 10291. [Google Scholar] [CrossRef]
- Sertić, Z.; Letilović, T.; Kanižaj, T.F.; Knotek, M.; Hadžibegović, I.; Starovečki, I.; Jerkić, H. Cardiovascular mortality in liver and kidney transplant recipients. Medicine 2021, 100, e26019. [Google Scholar] [CrossRef] [PubMed]
- Najafi, F.; Jamrozik, K.; Dobson, A.J. Understanding the ‘epidemic of heart failure’: A systematic review of trends in determinants of heart failure. Eur. J. Heart Fail. 2009, 11, 472–479. [Google Scholar] [CrossRef] [PubMed]
- Poulter, N. Global risk of cardiovascular disease. Heart 2003, 89, ii2–ii5. [Google Scholar] [CrossRef]
- Wakatsuki, T.; Schlessinger, J.; Elson, E.L. The biochemical response of the heart to hypertension and exercise. Trends Biochem. Sci. 2004, 29, 609–617. [Google Scholar] [CrossRef]
- Nakamura, M.; Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 2018, 15, 387–407. [Google Scholar] [CrossRef]
- Cohn, J.N.; Ferrari, R.; Sharpe, N. Cardiac remodeling--concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 2000, 35, 569–582. [Google Scholar] [CrossRef] [PubMed]
- Kajstura, J.; Urbanek, K.; Rota, M.; Bearzi, C.; Hosoda, T.; Bolli, R.; Anversa, P.; Leri, A. Cardiac stem cells and myocardial disease. J. Mol. Cell. Cardiol. 2008, 45, 505–513. [Google Scholar] [CrossRef]
- Spinale, F.G. Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function. Physiol. Rev. 2007, 87, 1285–1342. [Google Scholar] [CrossRef]
- López, B.; González, A.; Querejeta, R.; Larman, M.; Díez, J. Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure. J. Am. Coll. Cardiol. 2006, 48, 89–96. [Google Scholar] [CrossRef]
- Weber, K.T. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation. Circulation 1997, 96, 4065–4082. [Google Scholar] [CrossRef]
- Patrichi, G.; Patrichi, A.; Satala, C.-B.; Sin, A.I. Matrix Metalloproteinases and Heart Transplantation—A Pathophysiological and Clinical View. Medicina 2023, 59, 1295. [Google Scholar] [CrossRef] [PubMed]
- Surówka, A.; Żołnierczuk, M.; Prowans, P.; Grabowska, M.; Kupnicka, P.; Markowska, M.; Szlosser, Z.; Kędzierska-Kapuza, K. The Effect of Chronic Immunosuppressive Regimen Treatment on Apoptosis in the Heart of Rats. Pharmaceuticals 2024, 17, 1188. [Google Scholar] [CrossRef]
- Haybar, H.; Bandar, B.; Torfi, E.; Mohebbi, A.; Saki, N. Cytokines and their role in cardiovascular diseases. Cytokine 2023, 169, 156261. [Google Scholar] [CrossRef]
- Sasayama, S.; Okada, M.; Matsumori, A. Chemokines and cardiovascular diseases. Cardiovasc. Res. 2000, 45, 267–269. [Google Scholar] [CrossRef] [PubMed]
- Gil, A.P. i R.J. Markery procesu zapalnego a niewydolność serca. Cardiol. J. 2004, 11, 861–871. [Google Scholar]
- Laing, K.J.; Secombes, C.J. Chemokines. Dev. Comp. Immunol. 2004, 28, 443–460. [Google Scholar] [CrossRef]
- Zlotnik, A.; Yoshie, O. Chemokines: A New Classification System and Their Role in Immunity. Immunity 2000, 12, 121–127. [Google Scholar] [CrossRef]
- Gao, S.-H.; Liu, S.-Z.; Wang, G.-Z.; Zhou, G.-B. CXCL13 in Cancer and Other Diseases: Biological Functions, Clinical Significance, and Therapeutic Opportunities. Life 2021, 11, 1282. [Google Scholar] [CrossRef] [PubMed]
- Waehre, A.; Halvorsen, B.; Yndestad, A.; Husberg, C.; Sjaastad, I.; Nygård, S.; Louch, W.; Reims, H.M.; Roald, B.; Dahl, C.P.; et al. Abstract 3395: The Homeostatic Chemokine CXCL13 and Its Receptor CXCR5 Are Regulated in Heart Failure and Are Involved in Cardiac Remodelling. Circulation 2009, 120, S801. [Google Scholar]
- Waehre, A.; Halvorsen, B.; Yndestad, A.; Husberg, C.; Sjaastad, I.; Nygård, S.; Dahl, C.P.; Ahmed, M.S.; Finsen, A.V.; Reims, H.; et al. Lack of chemokine signaling through CXCR5 causes increased mortality, ventricular dilatation and deranged matrix during cardiac pressure overload. PLoS ONE 2011, 6, e18668. [Google Scholar] [CrossRef]
- Wæhre, A. Chemokines in Cardiac Remodelling and Heart Failure, and Their Role in Regulation of Small Leucinerich Proteoglycans in The Extracellular Matrix. 2012. Available online: https://www.semanticscholar.org/paper/Chemokines-in-cardiac-remodelling-and-heart-and-in-W%C3%A6hre/b8683be296d50af5b8cce3457c516237f2258f0a (accessed on 18 March 2025).
- Dusi, V.; Ghidoni, A.; Ravera, A.; De Ferrari, G.M.; Calvillo, L. Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems. Mediators Inflamm. 2016, 2016, 5902947. [Google Scholar] [CrossRef]
- Zhao, F.; Bai, Y.; Xiang, X.; Pang, X. The role of fibromodulin in inflammatory responses and diseases associated with inflammation. Front. Immunol. 2023, 14, 1191787. [Google Scholar] [CrossRef]
- Kalamajski, S.; Liu, C.; Tillgren, V.; Rubin, K.; Oldberg, Å.; Rai, J.; Weis, M.; Eyre, D.R. Increased C-telopeptide cross-linking of tendon type I collagen in fibromodulin-deficient mice. J. Biol. Chem. 2014, 289, 18873–18879. [Google Scholar] [CrossRef] [PubMed]
- Kalamajski, S.; Bihan, D.; Bonna, A.; Rubin, K.; Farndale, R.W. Fibromodulin Interacts with Collagen Cross-linking Sites and Activates Lysyl Oxidase. J. Biol. Chem. 2016, 291, 7951–7960. [Google Scholar] [CrossRef] [PubMed]
- Schwarz, D.; Lipoldová, M.; Reinecke, H.; Sohrabi, Y. Targeting inflammation with collagen. Clin. Transl. Med. 2022, 12, e831. [Google Scholar] [CrossRef] [PubMed]
- Opałka, B.; Żołnierczuk, M.; Grabowska, M. Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review. J. Clin. Med. 2023, 12, 6935. [Google Scholar] [CrossRef]
- Penninga, L.; Møller, C.H.; Gustafsson, F.; Steinbrüchel, D.A.; Gluud, C. Tacrolimus versus cyclosporine as primary immunosuppression after heart transplantation: Systematic review with meta-analyses and trial sequential analyses of randomised trials. Eur. J. Clin. Pharmacol. 2010, 66, 1177–1187. [Google Scholar] [CrossRef]
- Nakata, Y.; Yoshibayashi, M.; Yonemura, T.; Uemoto, S.; Inomata, Y.; Tanaka, K.; Furusho, K. Tacrolimus and myocardial hypertrophy. Transplantation 2000, 69, 1960–1962. [Google Scholar] [CrossRef]
- Zeng, J.; Zhong, Q.; Feng, X.; Li, L.; Feng, S.; Fan, Y.; Song, T.; Huang, Z.; Wang, X.; Lin, T. Conversion From Calcineurin Inhibitors to Mammalian Target of Rapamycin Inhibitors in Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front. Immunol. 2021, 12, 663602. [Google Scholar] [CrossRef]
- Long, C.; Dietz, L.; Hamilton, S.; Wu, G.; Mitchell, B. FK506 Binding Protein 12/12.6 Depletion Increases Endothelial Nitric Oxide Synthase Threonine 495 Phosphorylation and Blood Pressure. Hypertension 2007, 49, 569–576. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Surówka, A.; Żołnierczuk, M.; Prowans, P.; Grabowska, M.; Kupnicka, P.; Markowska, M.; Szlosser, Z.; Zagrodnik, E.; Kędzierska-Kapuza, K. The Role of Chemokines and Small Leucine-Rich Proteoglycans in Cardiac Remodeling in Immunosuppressant-Treated Male Rats. Int. J. Mol. Sci. 2025, 26, 6414. https://doi.org/10.3390/ijms26136414
Surówka A, Żołnierczuk M, Prowans P, Grabowska M, Kupnicka P, Markowska M, Szlosser Z, Zagrodnik E, Kędzierska-Kapuza K. The Role of Chemokines and Small Leucine-Rich Proteoglycans in Cardiac Remodeling in Immunosuppressant-Treated Male Rats. International Journal of Molecular Sciences. 2025; 26(13):6414. https://doi.org/10.3390/ijms26136414
Chicago/Turabian StyleSurówka, Anna, Michał Żołnierczuk, Piotr Prowans, Marta Grabowska, Patrycja Kupnicka, Marta Markowska, Zbigniew Szlosser, Edyta Zagrodnik, and Karolina Kędzierska-Kapuza. 2025. "The Role of Chemokines and Small Leucine-Rich Proteoglycans in Cardiac Remodeling in Immunosuppressant-Treated Male Rats" International Journal of Molecular Sciences 26, no. 13: 6414. https://doi.org/10.3390/ijms26136414
APA StyleSurówka, A., Żołnierczuk, M., Prowans, P., Grabowska, M., Kupnicka, P., Markowska, M., Szlosser, Z., Zagrodnik, E., & Kędzierska-Kapuza, K. (2025). The Role of Chemokines and Small Leucine-Rich Proteoglycans in Cardiac Remodeling in Immunosuppressant-Treated Male Rats. International Journal of Molecular Sciences, 26(13), 6414. https://doi.org/10.3390/ijms26136414